Novel derivatives of psammaplin A, a method for their synthesis and their use for the prevention or treatment of cancer
Details for Australian Patent Application No. 2008238924 (hide)
International Classifications
Event Publications
10 September 2009 PCT application entered the National Phase
PCT publication WO2008/125988 Priority application(s): WO2008/125988
29 October 2009 Amendment Made
The nature of the amendment is: Amend the applicant to add add co-applicant's Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (INSERM); Unversidade de Vigo; Seconda Universita Degli Studi di Napoli and Radboud University Nijmegen
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser